Quick Answer
ClearPoint Neuro, Inc. reported Research And Development Expense of $13.90 million for the year ending 2025.
- ClearPoint Neuro, Inc. showed an increase of +12.1% in Research And Development Expense from 2024 to 2025.
- This data is from ClearPoint Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), ClearPoint Neuro, Inc.'s Research And Development Expense has grown by 144.6%.
- Historical annual values: Fiscal year 2025: $13.90 million | Fiscal year 2024: $12.39 million | Fiscal year 2023: $11.71 million | Fiscal year 2022: $10.89 million | Fiscal year 2021: $9.28 million | Fiscal year 2020: $4.69 million | Fiscal year 2019: $2.81 million | Fiscal year 2018: $2.31 million | Fiscal year 2017: $2.81 million | Fiscal year 2016: $2.63 million | Fiscal year 2015: $1.96 million | Fiscal year 2014: $3.30 million | Fiscal year 2013: $2.92 million | Fiscal year 2012: $2.48 million | Fiscal year 2011: $4.25 million | Fiscal year 2010: $5.68 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: